0001209191-23-050161.txt : 20230920 0001209191-23-050161.hdr.sgml : 20230920 20230920162934 ACCESSION NUMBER: 0001209191-23-050161 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230918 FILED AS OF DATE: 20230920 DATE AS OF CHANGE: 20230920 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: LASEZKAY GEORGE M CENTRAL INDEX KEY: 0001020514 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37783 FILM NUMBER: 231266797 MAIL ADDRESS: STREET 1: 1301 SECOND AVE., SUITE 4200 CITY: SEATTLE STATE: WA ZIP: 98101 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Clearside Biomedical, Inc. CENTRAL INDEX KEY: 0001539029 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 452437375 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 900 NORTH POINT PARKWAY STREET 2: SUITE 200 CITY: ALPHARETTA STATE: GA ZIP: 30005 BUSINESS PHONE: 678-270-3631 MAIL ADDRESS: STREET 1: 900 NORTH POINT PARKWAY STREET 2: SUITE 200 CITY: ALPHARETTA STATE: GA ZIP: 30005 4 1 doc4.xml FORM 4 SUBMISSION X0508 4 2023-09-18 0 0001539029 Clearside Biomedical, Inc. CLSD 0001020514 LASEZKAY GEORGE M C/O CLEARSIDE BIOMEDICAL, INC. 900 NORTH POINT PARKWAY, SUITE 200 ALPHARETTA GA 30005 1 1 0 0 CEO 0 Employee Stock Option (right to buy) 0.849 2023-09-18 4 A 0 200000 0.00 A 2033-09-18 Common Stock 200000 200000 D One-third of the shares underlying this option vest on September 18, 2024 and the balance of the shares vest in a series of 24 successive equal monthly installments thereafter, subject to the Reporting Person's continuous service as of each such vesting date. /s/ Mark Ballantyne, Attorney-in-Fact 2023-09-20